Brief: Guerbet Announces Approval For Lipiodol Ultra‐Fluide In Denmark
Nov 19 (Reuters) - Guerbet SA GRBT.PA :
* LIPIODOL ULTRA‐FLUIDE IS NOW AUTHORIZED IN DENMARK IN
CONVENTIONAL TRANS-ARTERIAL CHEMOEMBOLIZATION OF MID-STAGE
HEPATOCELLULAR CARCINOMA
Source text : https://bit.ly/2D0mrPq
Further company coverage: GRBT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Guerbet SA
See all newsBrief: Guerbet Q1 Revenue At EUR 177.4 Mln
Guerbet Q1 revenue up 2.6% at CER on increased volumes in EMEA and Asia
Medical imaging firm Guerbet's 2025 revenue falls on lower sales activity in France
Brief: Guerbet Says FDA Approves Labeling Update For Guerbet's Elucirem Injection
France's Guerbet misses 2025 revenue estimates